MARKET

CHE

CHE

Chemed Corp
NYSE
549.27
+8.30
+1.53%
After Hours: 549.27 -0.16 -0.03% 16:03 07/26 EDT
OPEN
544.56
PREV CLOSE
540.97
HIGH
553.95
LOW
541.53
VOLUME
132.67K
TURNOVER
0
52 WEEK HIGH
654.62
52 WEEK LOW
491.81
MARKET CAP
8.32B
P/E (TTM)
27.86
1D
5D
1M
3M
1Y
5Y
1D
Oppenheimer Remains a Buy on Chemed (CHE)
TipRanks · 1d ago
CHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q2 2024
Chemed reported earnings per share of $5.47 for the second quarter of 2024. The company reported revenue of $595.88 million. Chemed's revenue was 0.55% lower than the analyst estimate for the same period. The stock is down 2.7% this morning.
Investorplace · 2d ago
Chemed (CHE) Misses Q2 Earnings and Revenue Estimates
NASDAQ · 2d ago
Chemed Corp. Q2 Profit Increases, But Misses Estimates
NASDAQ · 2d ago
Chemed Non-GAAP EPS of $5.47 misses by $0.12, revenue of $595.9M misses by $3.3M
Earnings News Chemed Non-GAAP EPS of $5.47 misses by $0.12, revenue of $595.9M misses by $3.3M. VITAS segment operating results: Net Patient Revenue of $374.6 million. Full-year 2024 earnings per diluted share estimated to be $23.80.
Seeking Alpha · 2d ago
Chemed Raises FY24 EPS From $23.30-$23.70 To $23.55-$23.80 Vs $23.21 Est.
VITAS 2024 revenue, prior to Medicare Cap, is estimated to increase 16.3% to 17.3%. The cost of the retention program negatively impacted VITAS' 2023 full year adjusted EBITDA by 159 basis points. Covenant Health is expected to contribute approximately $30 million to $32 million of revenue in calendar 2024.
Benzinga · 2d ago
Chemed Q2 Adj $5.47 Misses $5.59 Estimate, Sales $595.88M Miss $599.19M Estimate
Chemed reported quarterly earnings of $5.47 per share. The company reported quarterly sales of $595.88 million which missed the analyst consensus estimate of $599.19 million. This is a 34.07 percent increase over the same period last year. Chemed also missed quarterly sales by 2.15 percent.
Benzinga · 2d ago
Chemed: Q2 Earnings Snapshot
Chemed Corp. Reports second-quarter earnings of $70.9 million. Cincinnati-based company expects full-year earnings in the range of $23.80 per share. The company posted revenue of $595. 9 million in the period. Chemed shares have declined 6% since the beginning of the year.
Barchart · 2d ago
More
About CHE
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.

Webull offers Chemed Corp stock information, including NYSE: CHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHE stock methods without spending real money on the virtual paper trading platform.